147 related articles for article (PubMed ID: 31923008)
1. Physical Activity in Adults With Wearable Cardioverter Defibrillators in the Post-Myocardial Infarction Period.
Tripp C; Burch AE; Erath JW; Hain A; Sears SF
J Cardiopulm Rehabil Prev; 2020 May; 40(3):164-166. PubMed ID: 31923008
[TBL] [Abstract][Full Text] [Related]
2. Effective treatment of electrical storm by a wearable cardioverter defibrillator in a patient with severely impaired left ventricular function after myocardial infarction: a case report.
Andresen H; Sasko B; Patschan D; Pagonas N; Ritter O
J Med Case Rep; 2021 May; 15(1):243. PubMed ID: 33993888
[TBL] [Abstract][Full Text] [Related]
3. Use of the wearable cardioverter-defibrillator - the Swiss experience.
Kovacs B; Reek S; Sticherling C; Schaer B; Linka A; Ammann P; Brenner R; Krasniqi N; Müller AS; Dzemali O; Kobza R; Grebmer C; Haegeli L; Berg J; Mayer K; Schläpfer J; Domenichini G; Reichlin T; Roten L; Burri H; Eriksson U; Saguner AM; Steffel J; Duru F; Swiss Wcd Registry
Swiss Med Wkly; 2020 Sep; 150():w20343. PubMed ID: 33035354
[TBL] [Abstract][Full Text] [Related]
4. Wearable cardioverter-defibrillator use in patients perceived to be at high risk early post-myocardial infarction.
Epstein AE; Abraham WT; Bianco NR; Kern KB; Mirro M; Rao SV; Rhee EK; Solomon SD; Szymkiewicz SJ
J Am Coll Cardiol; 2013 Nov; 62(21):2000-2007. PubMed ID: 23916930
[TBL] [Abstract][Full Text] [Related]
5. The US Experience of the Wearable Cardioverter-Defibrillator in Pediatric Patients.
Spar DS; Bianco NR; Knilans TK; Czosek RJ; Anderson JB
Circ Arrhythm Electrophysiol; 2018 Jul; 11(7):e006163. PubMed ID: 29945928
[TBL] [Abstract][Full Text] [Related]
6. Physical activity is reduced prior to ventricular arrhythmias in patients with a wearable cardioverter defibrillator.
Burch AE; D'Souza B; Gimbel JR; Rohrer U; Masuda T; Sears S; Scherr D
Clin Cardiol; 2020 Jan; 43(1):60-65. PubMed ID: 31710766
[TBL] [Abstract][Full Text] [Related]
7. Wearable cardioverter-defibrillator in patients with a transient risk of sudden cardiac death: the WEARIT-France cohort study.
Garcia R; Combes N; Defaye P; Narayanan K; Guedon-Moreau L; Boveda S; Blangy H; Bouet J; Briand F; Chevalier P; Cottin Y; Da Costa A; Degand B; Deharo JC; Eschalier R; Extramiana F; Goralski M; Guy-Moyat B; Guyomar Y; Hermida JS; Jourda F; Lellouche N; Mahfoud M; Manenti V; Mansourati J; Martin A; Pasquié JL; Ritter P; Rollin A; Tibi T; Yalioua A; Gras D; Sadoul N; Piot O; Leclercq C; Marijon E
Europace; 2021 Jan; 23(1):73-81. PubMed ID: 33257972
[TBL] [Abstract][Full Text] [Related]
8. Use of the wearable cardioverter defibrillator in high-risk cardiac patients: data from the Prospective Registry of Patients Using the Wearable Cardioverter Defibrillator (WEARIT-II Registry).
Kutyifa V; Moss AJ; Klein H; Biton Y; McNitt S; MacKecknie B; Zareba W; Goldenberg I
Circulation; 2015 Oct; 132(17):1613-9. PubMed ID: 26316618
[TBL] [Abstract][Full Text] [Related]
9. Wearable Cardioverter-Defibrillator-Measured Step Count for the Surveillance of Physical Fitness during Cardiac Rehabilitation.
Kovacs B; Müller F; Niederseer D; Krasniqi N; Saguner AM; Duru F; Hermann M
Sensors (Basel); 2021 Oct; 21(21):. PubMed ID: 34770361
[TBL] [Abstract][Full Text] [Related]
10. Experience With Wearable Cardioverter-Defibrillators at 2 Academic Medical Centers.
Leyton-Mange JS; Hucker WJ; Mihatov N; Reynolds M; Albert C; Lubitz SA; Milan DJ
JACC Clin Electrophysiol; 2018 Feb; 4(2):231-239. PubMed ID: 29749943
[TBL] [Abstract][Full Text] [Related]
11. Outcomes during and after the use of the wearable cardioverter-defibrillator in a tertiary-care and a regional hospital in Switzerland.
Kovacs B; Reek S; Saguner AM; Krasniqi N; Eriksson U; Duru F
Swiss Med Wkly; 2019 Nov; 149():w20136. PubMed ID: 31707723
[TBL] [Abstract][Full Text] [Related]
12. Comparison of the Outcome of Patients Protected by the Wearable Cardioverter Defibrillator (WCD) for <90 Wear Days
Dreher TC; El-Battrawy I; RÖger S; Rosenkaimer SL; Gerhards S; Kuschyk J; Borggrefe M; Akin I
In Vivo; 2020; 34(6):3601-3610. PubMed ID: 33144474
[TBL] [Abstract][Full Text] [Related]
13. Potential cost-effectiveness of wearable cardioverter-defibrillator for patients with implantable cardioverter-defibrillator explant in a high-income city of China.
Jiang X; Ming WK; You JHS
J Cardiovasc Electrophysiol; 2019 Nov; 30(11):2387-2396. PubMed ID: 31502350
[TBL] [Abstract][Full Text] [Related]
14. Experience with the wearable cardioverter-defibrillator in older patients: Results from the Prospective Registry of Patients Using the Wearable Cardioverter-Defibrillator.
Daimee UA; Vermilye K; Moss AJ; Goldenberg I; Klein HU; McNitt S; Zareba W; Kutyifa V
Heart Rhythm; 2018 Sep; 15(9):1379-1386. PubMed ID: 29678779
[TBL] [Abstract][Full Text] [Related]
15. Wearable cardioverter defibrillators for patients with long QT syndrome.
Owen HJ; Bos JM; Ackerman MJ
Int J Cardiol; 2018 Oct; 268():132-136. PubMed ID: 30041777
[TBL] [Abstract][Full Text] [Related]
16. Collaborative care for the wearable cardioverter defibrillator patient: Getting the patient and medical team "vested and active".
Sears SF; Tripp C; Huber NL; Khan S; Nekkanti R; Burch AE; Pokorney SD
J Cardiovasc Electrophysiol; 2020 Sep; 31(9):2509-2515. PubMed ID: 32757437
[TBL] [Abstract][Full Text] [Related]
17. Benefit of the Wearable Cardioverter-Defibrillator in Protecting Patients After Implantable-Cardioverter Defibrillator Explant: Results From the National Registry.
Ellenbogen KA; Koneru JN; Sharma PS; Deshpande S; Wan C; Szymkiewicz SJ
JACC Clin Electrophysiol; 2017 Mar; 3(3):243-250. PubMed ID: 29759518
[TBL] [Abstract][Full Text] [Related]
18. Therapy optimization in patients with heart failure: the role of the wearable cardioverter-defibrillator in a real-world setting.
Röger S; Rosenkaimer SL; Hohneck A; Lang S; El-Battrawy I; Rudic B; Tülümen E; Stach K; Kuschyk J; Akin I; Borggrefe M
BMC Cardiovasc Disord; 2018 Mar; 18(1):52. PubMed ID: 29544442
[TBL] [Abstract][Full Text] [Related]
19. Study of the wearable cardioverter defibrillator in advanced heart-failure patients (SWIFT).
Barsheshet A; Kutyifa V; Vamvouris T; Moss AJ; Biton Y; Chen L; Storozynsky E; Wan C; Szymkiewicz SJ; Goldenberg I
J Cardiovasc Electrophysiol; 2017 Jul; 28(7):778-784. PubMed ID: 28429542
[TBL] [Abstract][Full Text] [Related]
20. Use of the wearable cardioverter-defibrillator (WCD) and WCD-based remote rhythm monitoring in a real-life patient cohort.
Zylla MM; Hillmann HAK; Proctor T; Kieser M; Scholz E; Zitron E; Katus HA; Thomas D
Heart Vessels; 2018 Nov; 33(11):1390-1402. PubMed ID: 29721674
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
